Akari Therapeutics (AKTX) Change in Cash (2014 - 2026)
Akari Therapeutics recorded quarterly Change in Cash of -$2.4 million in Q1 2026, down 189.55% quarter-over-quarter from $2.7 million in Q4 2025, and down 14223.53% year-over-year from N/an in Q1 2025.
Akari Therapeutics' Change in Cash history runs 13 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- In Q1 2026, Change in Cash fell 14223.53% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at $186000.0 (down 86.04% YoY), while the FY2025 annual figure was $2.6 million, up 319.56% from the prior year.
- Change in Cash came in at -$2.4 million for Q1 2026 at Akari Therapeutics, down from $2.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $7.4 million in Q1 2022 to a low of -$8.6 million in Q2 2022.
- A 5-year average of -$775472.9 and a median of -$886000.0 in 2023 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash jumped 558.35% in 2025 and sank 14223.53% in 2026, its largest moves.
- Akari Therapeutics' Change in Cash stood at -$8.6 million in 2022, then soared by 89.66% to -$886000.0 in 2023, then soared by 146.61% to $413000.0 in 2024, then surged by 558.35% to $2.7 million in 2025, then sank by 189.55% to -$2.4 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$2.4 million, $2.7 million, and -$227000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 57.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.44 Mn |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | -227,000.00 |
| Jun 30, 2025 | 129,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | 413,000.00 |
| Sep 30, 2024 | -1.93 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | -2.54 Mn |
| Dec 31, 2023 | -886,000.00 |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -4.40 Mn |
| Mar 31, 2023 | -1.67 Mn |
| Jun 30, 2022 | -8.57 Mn |
| Mar 31, 2022 | 7.36 Mn |
| Dec 31, 2021 | 664.79 Bn |
| Sep 30, 2021 | -664.78 Bn |
| Jun 30, 2021 | -2.88 Mn |
| Mar 31, 2021 | -7.39 Mn |
| Dec 31, 2020 | -6,586.10 Bn |
| Sep 30, 2020 | 6,586.10 Bn |
| Jun 30, 2020 | -2,090.48 Bn |
| Mar 31, 2020 | 2,090.49 Bn |
| Dec 31, 2019 | -536,976.00 |
| Sep 30, 2019 | 3.51 Mn |
| Jun 30, 2019 | -3.54 Mn |
| Mar 31, 2019 | 325,512.00 |
| Dec 31, 2018 | -4.25 Mn |
| Sep 30, 2018 | -5.38 Mn |
| Jun 30, 2018 | -8.33 Mn |
| Mar 31, 2018 | -4.33 Mn |
| Dec 31, 2017 | 7.13 Mn |
| Sep 30, 2017 | -9.14 Mn |
| Jun 30, 2017 | 5.20 Mn |
| Mar 31, 2017 | -9.18 Mn |
| Dec 31, 2016 | 28.57 Mn |
| Sep 30, 2016 | -4.14 Mn |
| Jun 30, 2016 | -51.77 Mn |
| Mar 31, 2016 | -7.49 Mn |
| Dec 31, 2015 | -9.85 Mn |
| Sep 30, 2015 | 78.57 Mn |
| Jun 30, 2015 | -1.13 Mn |
| Mar 31, 2015 | -2.00 Mn |
| Dec 31, 2014 | 3.27 Mn |
| Sep 30, 2014 | -4.20 Mn |
| Jun 30, 2014 | -2.47 Mn |
| Mar 31, 2014 | 6.17 Mn |